Radioreceptor Assay for α;-Msh Using Mouse B16 Melanoma Cells

References

• Eberle A. N. The melanotropins. Chemistry, physiology and mechanism of action. Karger, Basel 1988
   Google Scholar
• Eberle A. N., de Graan P. N.E., Baumann J. B., Girard J., van Hees G., van de Veerdonk F. C.G. Structural requirements of α-MSH for the stimulation of MSH receptors on different pigment cells. Pigment Cell 1985, J. Bagnara, et al. University of Tokyo Press, Tokyo 1985; 191–196
   Google Scholar
• Hruby V. J., Wilkes B. C., Cody W. L., Sawyer T. K., Hadley M. E. Melanotropins: structural, conformational and biological considerations in the development of superpotent and superprolonged analogs. Peptide and protein reviews, M. T.W. Hearn. Dekker, New York 1984; vol 3: 1–64
   Google Scholar
• Bitensky M. W., Demopoulos H. B., Russell V. MSH-responsive adenyl cyclase in the Cloudman S91 melanoma. Pigmentation, its genesis and biologic control, V. Riley. Appleton-Century-Crofts, New York 1973; 247–255
   Google Scholar
• Fuller B. B., Lunsford J. B., Iman D. S. α-Me-lanocyte-stimulating hormone regulation of tyrosinase in Cloudman S-91 mouse melanoma cell culture. J. Biol. Chem. 1987; 262: 4024–4033
   PubMed Web of Science ®Google Scholar
• Siegrist W., Eberle A. N. In situ melanin assay for MSH using mouse B16 melanoma cells in culture. Anal. Biochem. 1986; 159: 191–197
   PubMed Web of Science ®Google Scholar
• Eberle A. N., Kriwaczek V. M., Schwyzer R. Studies on tyrosinase stimulation, binding and degradation of α-MSH interacting with non-synchronized mouse melanoma cells in culture. Peptides, structure and biological function, E. Gross, J. Meienhofer. Pierce Chem. Company, Rockford, Ill. 1979; 1033–1036
   Google Scholar
• Lambert D. T., Whitcombe P. E., Moellmann G. E., Lerner A. B. Basic characterization of the receptor for MSH on Cloudman S91 melanoma cells. Pigment Cell 1985, J. Bagnara, et al. Tokyo University Press. 1985; 165–174
   Google Scholar
• Eberle A. N., Hübscher W. α-Melanotropin labelled at its tyrosine2 residue: synthesis and biological activities of 3′-iodotyrosine2-,3′-125iodo-tyrosine2-, 3′,5′-diiodotyrosine2-and (3′,5′-3H2)-tyrosine2-α-melanotropin, and of related peptides. Helv. Chim. Acta 1979; 62: 2460–2483
   Google Scholar
• Eberle A. N., Zeller A. Tritiation of peptides to high specific radioactivity. Part 1. Synthesis and biological properties of [13-(3H4)norvaline]-α-MSH and of [2,23-bis((3H2)tyrosine)]ACTH(1–24). Helv. Chim. Acta 1985; 68: 1880–1892
   Google Scholar
• Heward C. B., Yang Y. C.S., Ormberg J. F., Hadley M. E., Hruby V. J. Effects of chloramine T on the biological activity of melanotropin. Hoppe-Seyler's Z. Physiol. Chem. 1979; 360: 1851–1859
   PubMedGoogle Scholar
• Heward C. B., Kreutzfeld K. L., Hadley M. E., Larsen B., Sawyer T. K., Hruby V. J. Preparation of radiolabeled melanotropin suitable for use as a tracer in a radioreceptor assay: [125I-Tyr2, Nle4]-α-melanotropin. Pigment Cell 1981, M. Seiji. University of Tokyo Press, Tokyo 1981; 339–346
   Google Scholar
• Fidler I. J. Selection of successive tumour lines for metastasis. Nature New Biol. 1973; 242: 148–149
   PubMedGoogle Scholar
• Pomerantz S. H. L-tyrosine-3,5-3H assay for tyrosinase development in skin of new born hamsters. Science 1969; 164: 838–839
   Google Scholar
• Eberle A. N., Girard J. An Anolis skin melanophore assay suitable for photoaffinity labeling studies with α-MSH. Experientia 1985; 41: 654–656
   PubMedGoogle Scholar
• Munson P. J., Rodbard C. LIGAND: A versatile computerized approach for characterization of ligand-binding systems. Anal. Biochem. 1980; 107: 220–239
   PubMed Web of Science ®Google Scholar
• Lee C.-M., Sandberg B. E.B., Hanley M. R., Iversen L. L. Purification and characterisation of a membrane-bound substance-P-degrading enzyme from human brain. Eur. J. Biochem. 1981; 114: 315–327
   PubMedGoogle Scholar
• Gerst J. E., Sole J., Salomon Y. Dual regulation of β-melanotropin receptor function and adenylate cyclase by calcium and guanosine nucleotides in the M2R melanoma cell line. Mol. Pharmacol. 1987; 31: 81–88
   PubMed Web of Science ®Google Scholar
• Sawyer T. K., Sanfilippo P. J., Hruby V. J., Engel M. H., Heward C. B., Burnett J. B., Hadley M. E. 4-Norleucine, 7-D-phenylalanine-α-melanocyte stimulating hormone: a highly potent α-melanotropin with ultralong biological activity. Proc. Natl. Acad. Sci. USA 1980; 77: 5754–5758
   PubMed Web of Science ®Google Scholar
• Buckley D. I., Ramachandran J. Characterization of corticotropin receptors on adrenocortical cells. Proc. Natl. Acad. Sci. USA 1981; 78: 7431–7435
   PubMed Web of Science ®Google Scholar
• Gerst J. E., Sole J., Mather J. P., Salomon Y. Regulation of adenylate cyclase by β-melanotropin in the M2R melanoma cell line. Mol. Cell. Endocrinol. 1986; 46: 137–147
   PubMed Web of Science ®Google Scholar
• Lambert D. T., Lerner A. B. Optimization of a melanotropin-receptor binding assay by reversed-phase high-performance liquid chromatography. J. Chromatography 1983; 266: 567–576
   Google Scholar